Clinical Trial Update: Effect of 5 Years of GH Replacement on Atherosclerosis

View source ↗

Summary

A completed clinical trial assesses the impact of five years of growth hormone replacement on atherosclerosis in individuals with hypopituitarism and growth hor…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Growth Hormone Deficiency
• Hypopituitarism
• Pituitary Adenoma

Drugs mentioned

• Somatropin (somatropin)

Snippet

Sponsor: Federico II University | Conditions: Hypopituitarism, Pituitary Tumors | Status: COMPLETED